{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:51:33Z","timestamp":1778633493410,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.expneurol.2008.02.016","type":"journal-article","created":{"date-parts":[[2008,3,5]],"date-time":"2008-03-05T12:35:26Z","timestamp":1204720526000},"page":"329-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Moving towards therapies for Juvenile Batten disease?"],"prefix":"10.1016","volume":"211","author":[{"given":"Jonathan D.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2008.02.016_bib1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1089\/hum.2005.16.1028","article-title":"Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders","volume":"16","author":"Arkin","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2008.02.016_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF00607283","article-title":"MRI of neuronal ceroid lipofuscinosis: I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis","volume":"38","author":"Autti","year":"1996","journal-title":"Neuroradiology"},{"key":"10.1016\/j.expneurol.2008.02.016_bib3","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2008.02.016_bib4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/hmg\/11.12.1421","article-title":"An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease","volume":"11","author":"Chattopadhyay","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2008.02.016_bib5","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1212\/01.WNL.0000041913.97883.8B","article-title":"An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses","volume":"59","author":"Chattopadhyay","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.02.016_bib6","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","article-title":"Cln3\u0394ex7\/8 knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth","volume":"11","author":"Cotman","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2008.02.016_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1089\/hum.2004.15.1131","article-title":"Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis","volume":"15","author":"Crystal","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2008.02.016_bib8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10545-005-0125-7","article-title":"Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype","volume":"28","author":"de Voer","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib9","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1523\/JNEUROSCI.1710-07.2007","article-title":"A knock-in reporter model of Batten disease","volume":"27","author":"Eliason","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.02.016_bib10","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1242\/jcs.02656","article-title":"btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis","volume":"118","author":"Gachet","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.expneurol.2008.02.016_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","article-title":"Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of Infantile Neuronal Ceroid Lipofuscinosis (INCL)","volume":"16","author":"Griffey","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","article-title":"AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis","volume":"12","author":"Griffey","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2008.02.016_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","article-title":"CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"13","author":"Griffey","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2008.02.016_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/9.5.735","article-title":"Batten disease: evaluation of CLN3 mutations on protein localization and function","volume":"9","author":"Haskell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2008.02.016_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying Batten disease, CLN3","volume":"82","author":"International Batten Disease Consortium","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2008.02.016_bib16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/hmg\/8.6.1091","article-title":"Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)","volume":"8","author":"J\u00e4rvel\u00e4","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2008.02.016_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1078\/0940-2993-00301","article-title":"Behavioral phenotyping of mice in pharmacological and toxicological research","volume":"55","author":"Karl","year":"2003","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.expneurol.2008.02.016_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-4547(19990815)57:4<551::AID-JNR15>3.0.CO;2-R","article-title":"A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease)","volume":"57","author":"Katz","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2008.02.016_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2007.08.017","article-title":"Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"29","author":"Katz","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"Kielar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib21","doi-asserted-by":"crossref","first-page":"15458","DOI":"10.1073\/pnas.2136651100","article-title":"A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease","volume":"100","author":"Kim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2008.02.016_bib22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbadis.2006.05.007","article-title":"Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins","volume":"1762","author":"Kytt\u00e4l\u00e4","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2008.02.016_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2007.09.012","article-title":"Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease","volume":"209","author":"Kov\u00e1cs","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.02.016_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.nbd.2005.12.018","article-title":"Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease","volume":"22","author":"Kov\u00e1cs","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2990.2006.00738.x","article-title":"Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis","volume":"32","author":"Lim","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2008.02.016_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nbd.2006.09.005","article-title":"IgG entry and deposition are components of the neuroimmune response in Batten disease","volume":"25","author":"Lim","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-5793(03)01274-2","article-title":"Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease","volume":"555","author":"Mao","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2008.02.016_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The batten mouse model consortium","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","article-title":"Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses","volume":"6","author":"Mole","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.expneurol.2008.02.016_bib30","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1074\/jbc.M510625200","article-title":"Saccharomyces cerevisiae lacking Btn1p modulate vacuolar ATPase activity to regulate pH imbalance in the vacuole","volume":"281","author":"Padilla-L\u00f3pez","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.02.016_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/nen.0b013e31815f3899","article-title":"Synaptic changes in the thalamocortical system of cathepsin D deficient mice, a model of human congenital neuronal ceroid-lipofuscinosis","volume":"67","author":"Partanen","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.02.016_bib32","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.02.016_bib33","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1073\/pnas.95.12.6915","article-title":"A yeast model for the study of Batten disease","volume":"95","author":"Pearce","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2008.02.016_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/8861","article-title":"Action of BTN1, the yeast orthologue of the gene mutated in Batten disease","volume":"22","author":"Pearce","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2008.02.016_bib40","doi-asserted-by":"crossref","first-page":"42508","DOI":"10.1074\/jbc.M507380200","article-title":"High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease","volume":"280","author":"Pears","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.02.016_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","article-title":"Late onset neurodegeneration in the Cln3-\/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation","volume":"1023","author":"Pontikis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.02.016_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.nbd.2005.05.018","article-title":"Thalamocortical neuron loss and localized astrocytosis in the Cln3\u0394ex7\/8 knock-in mouse model of Batten disease","volume":"20","author":"Pontikis","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.02.016_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbadis.2006.05.006","article-title":"Molecular genetics of the NCLs \u2014 status and perspectives","volume":"1762","author":"Siintola","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2008.02.016_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced Survival of the LINCL Mouse Following CLN2 Gene Transfer Using the rh.10 Rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2008.02.016_bib39","first-page":"156","article-title":"HuCNS-SC (StemCells)","volume":"8","author":"Taupin","year":"2006","journal-title":"Curr. Opin. Mol. Ther."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608000903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608000903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:35:40Z","timestamp":1758000940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488608000903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0014488608000903"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.02.016","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moving towards therapies for Juvenile Batten disease?","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}